Efficacy and Safety Of Glucagon-Like Peptide-1 Receptor Agonists For The Treatment of Type 2 Diabetes Mellitus: A Network Meta-Analysis
Version 2 2021-02-10, 17:44
Version 1 2021-02-10, 16:59
media
posted on 2021-02-10, 17:44 authored by Yawen Jiang, Jia Liu, Xin Chen, Weiping Jia, Jing Wu<p><strong>Article full
text</strong></p>
<p> </p>
<p><br></p>
<p> </p>
<p>The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC 2021.</p>
